"Carl Icahn - one of Wall Street's most renowned and successful investors - is on another mission; this pitbull is sinking his teeth into one of the companies in our portfolio - Enzon Pharmaceuticals (NASDAQ: ENZN)," notes Marc Lichtenfeld.

In Xcelerated Profits Report, the senior analyst and noted healthcare sector expert takes a look at the small cap biotechnology, which is involved in developing products for the treatment of cancer.

"With an infamous reputation for diving into stocks that he perceives as undervalued and shaking up management teams in order to boost shareholder value, Icahn us one of the best 'business partners' we could have.

"One of the big reasons why we recommended Enzon was because some major institutional investors are clamoring for change at the company. They contend that if Enzon was better at maximizing its true potential, the stock could easily vault from its current undervalued state and generate some real wealth for its shareholders.

"My more conservative idea for 2008 is Wachovia (NYSE: WB)," says Karim Rahemtulla, investment director for Xcelerated Profits Report.

"While many investors are running in fear of the current climate, it actually offers smart investors a great chance to accelerate their profits. There is nothing like a hearty dose of fear to trigger a bout of bargain-hunting! And if you know where to look, there are plenty of bargains.

"You can even make money against all the odds and despite what Wall Street and the media want you to believe. History has proved this. While the masses ran for cover, smart investors stepped in and made serious money.

"And one of the best areas to do this is the financial sector. It's top of the bearish hit list right now, but it's actually packed with profit potential over the next 12 months. Top of our list is Wachovia.

For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.

"My more speculative idea for 2008 is Immersion (NASDAQ: IMMR)," says Karim Rahemtulla, investment director for Xcelerated Profits Report.

"This time last year, Immersion shares were trading in the single-digits. But when the company finally prevailed in its prolonged patent infringement lawsuit against Sony, the stock took off.

"The company is an industry leader in the field of 'haptics' and touch-sense technology. This is the kind of software you find in PlayStation gaming consoles and associated games – which makes the controller vibrate and puts gamers into the action more realistically.

"But the company also has major revenue streams in a variety of areas. In the medical industry, for example, its force-feedback technology is helping surgeons train in a more realistic way, replicating the motion in the human body. The medical segment is Immersion's biggest revenue generator, accounting for around 40% of annual revenues.